Asthma medication formoterol shows promise for treating fatty liver disease
View as a Web Page
News Medical
 
  Hepatology Hepatology logo  
  The latest hepatology news from News Medical  
 Study debunks steroid myths, framing creatine as an essential energy-providing moleculeStudy debunks steroid myths, framing creatine as an essential energy-providing molecule
 
Creatine, a compound often associated with gym-goers and athletes, has long been touted as a performance-enhancing supplement. But beyond the hype, what does science actually reveal about its effects on the body and mind?
 
 
 Asthma medication formoterol shows promise for treating fatty liver diseaseAsthma medication formoterol shows promise for treating fatty liver disease
 
MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds of millions worldwide.
 
   New AI model spots hidden pancreatic cancer long before diagnosisNew AI model spots hidden pancreatic cancer long before diagnosis
 
Mayo Clinic's AI model identifies invisible signs of pancreatic cancer on routine CT scans, potentially transforming early detection and survival rates.
 
   AI-driven model predicts type 1 diabetes risk with greater accuracyAI-driven model predicts type 1 diabetes risk with greater accuracy
 
Researchers use machine learning and genetic analysis to uncover type 1 diabetes risk factors, improving prediction accuracy and identifying patient subtypes.
 
   Inflammation from leaking mitochondria drives aggressive pancreatic cancer growthInflammation from leaking mitochondria drives aggressive pancreatic cancer growth
 
Scientists at The Wistar Institute and clinical researchers from ChristianaCare's Helen F. Graham Cancer Center & Research Institute have discovered a vulnerability in pancreatic cancer that could be targeted as a potential therapy.
 
 Cannabis compounds may improve metabolism and reduce diabetes risk
 
Cannabis compounds may improve metabolism and reduce diabetes riskA University of California, Riverside preclinical study is shedding light on a long-observed but poorly understood phenomenon: chronic cannabis users tend to have lower body weight and a reduced risk of developing type 2 diabetes, despite the drug's well-known tendency to increase appetite.
 
 
 Study reveals epigenetic adaptation of beta cells across lifespan and disease
 
Study reveals epigenetic adaptation of beta cells across lifespan and diseaseAs people age, most maintain normal blood sugar even as insulin resistance tends to rise. New research suggests that pancreatic beta cells help meet this demand through gradual epigenetic changes in regulatory regions of the genome that support beta-cell identity and function.
 
 
 How In Vitro Models Are Transforming Drug Discovery in Malaria
 
How In Vitro Models Are Transforming Drug Discovery in MalariaOrganoids and engineered systems are transforming malaria research, improving drug discovery and understanding of Plasmodium biology in global health contexts.
 
 
 Diabetes, weight-loss drugs not a perfect fit?
 
Diabetes, weight-loss drugs not a perfect fit?Type 2 diabetes affects millions of people worldwide and now a new international study, jointly led by Adelaide University, University of Oxford, ETH Zurich, and Stanford University, has found one in ten people may not be benefiting from common medications used to treat the condition.
 
 
 New technique uses electronic jolt and nanoparticles to reveal early signs of pancreatic cancer
 
New technique uses electronic jolt and nanoparticles to reveal early signs of pancreatic cancerScientists at Oregon Health & Science University have developed a new technique using an electronic jolt and nanoparticles to reveal the telltale signal of an insidious form of cancer.
 
 
 Six genes found to connect pancreatic cancer with metabolic dysfunction
 
Six genes found to connect pancreatic cancer with metabolic dysfunctionNew research shows that the same genes are active in pancreatic cancer, obesity and diabetes, helping to explain why people with metabolic disease often face poorer cancer outcomes and pointing to future ways to predict recurrence and develop more targeted treatments.
 
 
 Researchers identify new treatment vulnerabilities in pancreatic cancer progression
 
Researchers identify new treatment vulnerabilities in pancreatic cancer progressionThe review offers important insights for patients and families by explaining why pancreatic cancer has proven so resistant to treatment, and where new hope may emerge.
 
 
 Targeted RAS inhibitor shows promise against pancreatic cancer mutations
 
Targeted RAS inhibitor shows promise against pancreatic cancer mutationsThe targeted RAS inhibitor therapy daraxonrasib demonstrated the potential to improve patient outcomes over current standard treatments for patients with RAS-mutant pancreatic cancer, according to results of a Phase 1/2 trial led by researchers at The University of Texas MD Anderson Cancer Center.
 
 
 Liver fat may disrupt post-meal glucagon control in early type 2 diabetes
 
Liver fat may disrupt post-meal glucagon control in early type 2 diabetesResearchers found that MASLD, rather than type 2 diabetes alone, was linked to higher fasting glucagon levels in adults with newly diagnosed diabetes and matched controls. In people with early type 2 diabetes, higher liver fat was specifically associated with exaggerated early post-meal glucagon responses, independent of insulin sensitivity, visceral fat, amino acids, or NEFAs.
 
 
 Kyoto University identifies a key regulator of insulin production
 
Kyoto University identifies a key regulator of insulin productionA hallmark of Type 2 diabetes is the progressive loss of beta cell mass: cells in the pancreas that produce and release insulin. The endoplasmic reticulum stress response, a cellular pathway that maintains protein homeostasis, plays a critical role in beta cell function and survival, and the protein ATF6α is one of the key regulators of this stress response.
 
 
 Specific health labels may better motivate reduced alcohol consumption
 
Specific health labels may better motivate reduced alcohol consumptionAlthough the United States requires a warning label on alcoholic beverages, alcohol-related deaths have risen steadily over the past two decades.
 
 
 T1GRS model enhances prediction of genetic risk for Type 1 diabetes
 
T1GRS model enhances prediction of genetic risk for Type 1 diabetesIn people with Type 1 diabetes (T1D), the immune system shuts down the body's ability to make the hormone insulin, responsible for regulating blood sugar and providing cells with glucose to produce energy.
 
 
 Study challenges structural explanation for gut symptoms in hEDS patients
 
Study challenges structural explanation for gut symptoms in hEDS patientsA study, led by experts at the University of Nottingham, has found that persistent and distressing upper gut symptoms experienced by people with hypermobile Ehlers-Danlos syndrome (hEDS), are not due to structural problems with the gullet (esophagus), as previously assumed.
 
 
 Rhein protects against intestinal injury in severe acute pancreatitis
 
Rhein protects against intestinal injury in severe acute pancreatitisSevere acute pancreatitis (SAP) remains one of the most formidable challenges in gastrointestinal emergency medicine.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026